Summit Recap:
The goal of sponsoring the Boston Biotechnology Summit was to successfully add value to innovative companies by foster a community centered around collaboration. Which is why we helped design an environment to share the exciting advancements in our industry.
From the expert academic speakers to the pitch competition CEOs, each had a unique expertise in their field which made it a fascinating forum. Topics included economic drivers that impact the industry from a macro/micro level, vendor selection developments, outlook and application of AI systems, patient perspectives within clinical trials, resourcing strategies to facilitate company growth and even legal advice when dealing with intellectual properties and patents.
The Pitch Competition was at the heart of the summit which included:
STROKE AI - Cédric JAVAULT- The digital solution to diagnose strokes in real time.
THERANOVIR - Zakia BELAID-SANDAL- Implementation platform for connecting various pathological therapeutic areas by targeting signaling pathways.
Atticus - Ben Wills - The solution for eradicating scabies whilst having a focus on the application of medicines in other infectious diseases.
RS Therapeutics - Dean Hart - Pulmonary Inflammation therapeutics platform for respiratory diseases with a focus on steroid free - complex cannabinoid receptors.
PepKon - Jonathan Levy - First-in-class peptides for treatment of incurable or poor prognosis cancers.
Gencovery - Djomangan Adama OUATTARA - Developed Constellab to integrate all data to lead global data exchange networks to accelerate and optimize r&d and production pipelines.
Congratulations to CEO of PepKon, Jonthan Levy for being our 2024 Pitch Session Champion! And also, to Dean Hart, CEO of RS BioTherapeutics, Inc. for being our Vice-Champion.
Thank you to Shahin Gharakhanian,MD and Soheila Gharakhanian for partnering with us in what was ultimately a successful night of sharing innovative ideas and fostering collaboration within the community.
Thank you to Consulate General of France in Boston for inviting the team to the reception hosted at the Residence, and cheers to all NETVA teams that pitched.
Cpl Life Sciences US' aim will continue to be centered on nurturing the life science community through joint efforts and partnerships.
We have worked and met with many organizations looking to continuing developing these environments to share wisdom and foster partnerships to help patients in need.
Medidata:
Medidata Solutions for a robust and immersive summit showcasing their client centered focused solutions and support.
There was a workshop designing eCOAs on their platforms, and multiple informative insights from speakers on efficiently managing data systems and complex trial designs.
In our attendance, there were discussions on innovative approaches for complex clinical trials, key factors for clinical development teams when designing trials, AI integration for medical imaging, and their overarching goal of clinical trials being more accessible while inviting patients to be more interactive on their platforms.
This event served as a testament on how transformative the life science industry has become and is becoming. While putting into perspective the strategic focus many companies have to consider for the success of their trials and ultimately their patients.
👏👏Big appreciation to the key speakers Kevin Stephenson, Helen Madison (Fresenius), Kathy Zheng, William Blumentals, Bryant Fields, Tanmay Jain, Andrew Creedon, Andrea Falkoff, Michelle Hartmann, Jamie Goldfarb, Alicia C. Staley and many others I may of missed for sharing your prospectives and outlook of the innovation that is coming to our industry.
It was great to sit and learn the complexities of biometrics and data teams.
Our focus to move the industry forward will be to continually develop and improve our life science communities.
Defining problems and sharing solutions to instill a culture of collaboration - collaboration across different departments, job functions, and companies with the end goal of helping each other grow.
📍Boston is the place to do this at and I encourage everyone from venture capitalists, executives, researchers, commercial development, clinical operations, and everything in between to be interactive in the community and share their insights and perspectives and contribute to the community!
